Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Hongcao Lin

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5078974631. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers · 2023: none · 2024: 1 paper

Papers 4

  1. AHNAK2 Promotes the Progression of Pancreatic Ductal Adenocarcinoma by Maintaining the Stability of c-MET. Co-author DOI 10.2147/cmar.s451486↗
  2. Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair. Co-author DOI 10.1038/s41388-022-02253-6↗
  3. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway. Co-author DOI 10.1186/s13046-021-02237-6↗
  4. A novel gene signature for prognosis prediction and chemotherapy response in patients with pancreatic cancer. Co-author DOI 10.18632/aging.202922↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chonghui Hu · 3 shared papers, 2021–2022 · strength 0.45
  2. Quanbo Zhou · 3 shared papers, 2021–2022 · strength 0.45
  3. Shangyou Zheng · 3 shared papers, 2021–2022 · strength 0.45
  4. Yanan Lu · 1 shared paper, 2024 · strength 0.31
  5. Z Chen · 1 shared paper, 2024 · strength 0.31
  6. Rufu Chen · 2 shared papers, 2021–2022 · strength 0.30
  7. Renpeng Xia · 2 shared papers, 2022 · strength 0.29
  8. Xiang Zhang · 1 shared paper, 2021 · strength 0.16
  9. Xiang Zhang · 1 shared paper, 2022 · strength 0.15
  10. Rufu Chen · 1 shared paper, 2022 · strength 0.15
  11. Zhihua Li · 1 shared paper, 2022 · strength 0.15
  12. Xiang Zhang · 1 shared paper, 2022 · strength 0.14
  13. Rihua He · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.